Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

Question 2

How does lapatinib compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from lapatinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer clinical trial (NCT00359190). Contact the study team or your healthcare provider for specific answers.

What this study is about